Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group (Q46856637)
Jump to navigation
Jump to search
scientific article published in December 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group |
scientific article published in December 2005 |
Statements
1 reference
Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group (English)
1 reference
1 reference
Eric Van Cutsem
1 reference
Theo Wagener
1 reference
Jean-Luc Van Laethem
1 reference
Udo Vanhoefer
1 reference
Jacques A Wils
1 reference
Eric Gamelin
1 reference
Claus H Koehne
1 reference
Jean P Arnaud
1 reference
Emmanuel Mitry
1 reference
Faress Husseini
1 reference
Peter Reichardt
1 reference
Mustafa El-Serafi
1 reference
Pierre-Luc Etienne
1 reference
Thomas Lingenfelser
1 reference
Michel Praet
1 reference
Bruno Genicot
1 reference
Muriel Debois
1 reference
Bernard Nordlinger
1 reference
Michel P Ducreux
1 reference
European Organisation for Research and Treatment of Cancer Gastrointestinal Group
1 reference
1 December 2005
1 reference
23
1 reference
36
1 reference
9250-9256
1 reference